Tomohisa Mori Selected Research

Tomohisa Mori Research Topics

Disease

12	Pain (Aches) 01/2021 - 09/2009
7	Neuralgia (Stump Neuralgia) 07/2022 - 01/2014
6	Substance-Related Disorders (Drug Abuse) 01/2022 - 12/2004
4	Schizophrenia (Dementia Praecox) 01/2022 - 02/2012
4	Hyperalgesia 01/2022 - 01/2014
4	Body Weight (Weight, Body) 10/2014 - 08/2006
3	Hallucinations (Hallucination) 01/2022 - 01/2012
2	Neoplasms (Cancer) 01/2022 - 09/2009
2	Rupture 01/2018 - 07/2007
2	Constipation 01/2016 - 10/2013
2	Narcolepsy 01/2016 - 03/2010
2	Bone Neoplasms (Bone Cancer) 04/2015 - 01/2014
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 10/2014 - 09/2013
2	Diarrhea 10/2014 - 09/2013
2	Acquired Immunodeficiency Syndrome (AIDS) 06/2013 - 12/2011
2	HIV Infections (HIV Infection) 07/2012 - 12/2011
1	Chronic Pain 01/2022
1	Postoperative Pain 01/2021
1	Breakthrough Pain 01/2021
1	Sleep Wake Disorders 01/2016
1	Psychotic Disorders (Schizoaffective Disorder) 01/2016
1	Hypersensitivity (Allergy) 04/2015
1	Muscle Rigidity 01/2014
1	Parkinsonian Disorders (Parkinsonism) 06/2012
1	Parkinson Disease (Parkinson's Disease) 06/2012
1	Paralysis (Palsy) 05/2012
1	Postmortem Changes (Adipocere) 01/2011
1	Stroke (Strokes) 09/2009

Drug/Important Bio-Agent (IBA)

12	Morphine (MS Contin)FDA LinkGeneric 07/2022 - 07/2007
11	Opioid Receptors (Opioid Receptor)IBA 07/2022 - 11/2012
5	Opioid Analgesics (Opioids)IBA 07/2022 - 12/2004
5	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 06/2012
5	Oxycodone (Oxycontin)FDA LinkGeneric 04/2015 - 09/2013
4	Pharmaceutical PreparationsIBA 01/2018 - 07/2007
4	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2018 - 07/2007
4	Fentanyl (Sublimaze)FDA LinkGeneric 01/2017 - 09/2013
4	Naloxone (Narcan)FDA LinkGeneric 07/2015 - 12/2007
3	Narcotic Antagonists (Opioid Antagonists)IBA 07/2015 - 09/2013
3	FullerenesIBA 10/2014 - 08/2006
2	((3- methoxythiophen- 2- yl)methyl)((2- (9- (pyridin- 2- yl)- 6- oxaspiro(4.5)decan- 9- yl)ethyl))amineIBA 01/2021 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2021 - 07/2015
2	Ketamine FDA LinkGeneric 01/2018 - 01/2012
2	Illicit Drugs (Recreational Drugs)IBA 01/2018 - 01/2012
2	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2018 - 01/2012
2	Phencyclidine (Angel Dust)IBA 01/2018 - 01/2012
2	Dopamine Receptors (Dopamine Receptor)IBA 01/2016 - 01/2007
2	OrexinsIBA 01/2016 - 03/2010
2	Pentazocine (Talwin)FDA LinkGeneric 07/2015 - 03/2015
2	LigandsIBA 03/2015 - 06/2012
2	Sigma-1 ReceptorIBA 03/2015 - 09/2009
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2014 - 01/2014
2	naloxonazineIBA 10/2013 - 09/2013
2	N-methylnaloxoneIBA 10/2013 - 09/2013
2	Cocaine (Cocaine HCl)IBA 07/2012 - 12/2011
1	G Protein-Coupled Inwardly-Rectifying Potassium ChannelsIBA 07/2022
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 07/2022
1	QuinpiroleIBA 01/2022
1	GSK-J4IBA 01/2021
1	antineoplaston A10 (A 10)IBA 01/2021
1	Histones (Histone)IBA 01/2021
1	AnnexinsIBA 01/2021
1	GTP-Binding Proteins (G-Protein)IBA 01/2021
1	Cornified Envelope Proline-Rich ProteinsIBA 01/2021
1	CannabinoidsIBA 01/2018
1	PLIalphaIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2016
1	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA 01/2016
1	Therapeutic UsesIBA 01/2016
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2016
1	5-HT1A Serotonin ReceptorIBA 01/2016
1	Formaldehyde (Formol)FDA Link 07/2015
1	naltrindoleIBA 07/2015
1	pre-prodynorphinIBA 07/2015
1	Ondansetron (Zofran)FDA LinkGeneric 10/2014
1	Olanzapine (Zyprexa)FDA Link 10/2014
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 10/2014
1	Atropine FDA LinkGeneric 10/2014
1	Free Radical ScavengersIBA 10/2014
1	RitanserinIBA 10/2014
1	MuscarineIBA 10/2014
1	Zolpidem (Ambien)FDA LinkGeneric 09/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2014
1	tertiapinIBA 01/2014
1	Hypnotics and Sedatives (Sedatives)IBA 06/2013
1	BenzodiazepinesIBA 06/2013
1	Anti-Anxiety Agents (Anxiolytics)IBA 06/2013
1	Dronabinol (THC)FDA LinkGeneric 11/2012
1	Cannabinoid Receptor AgonistsIBA 11/2012
1	Antipsychotic Agents (Antipsychotics)IBA 02/2012
1	Lysergic Acid Diethylamide (LSD)IBA 01/2012
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2011
1	Human Immunodeficiency Virus ProteinsIBA 12/2011
1	5,5- dimethyl- 5- hydroperoxy- 1- pyrrolidinyloxyIBA 01/2011
1	Ataxin-3IBA 03/2010

Therapy/Procedure

5	Ligation 07/2022 - 01/2016
1	Transplantation 01/2022
1	Electrocoagulation (Electrocautery) 01/2021
1	Therapeutics 07/2012
1	Laryngoplasty 05/2012
1	Anesthesia 05/2012